Francis E. Odonnell Jr.

Chief Executive Officer, ACCENTIA BIOPHARMACEUTICALS INC.

Companies

Inhibitor Therapeutics, Inc.Chief executive officer Aug 4, 2026 to now¹
Inhibitor Therapeutics, Inc.Board member Dec 22, 2022 to now²
Inhibitor Therapeutics, Inc.Officer Dec 22, 2022 to Dec 22, 2022²
BIODELIVERY SCIENCES INTERNATIONAL INCBoard member Jan 12, 2007 to May 14, 2020³
Inhibitor Therapeutics, Inc.Chair Aug 16, 2013 to Jun 20, 2016⁴
BIODELIVERY SCIENCES INTERNATIONAL INCChair Feb 13, 2015 to Feb 13, 2015⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Inhibitor Therapeutics, Inc. INTI85,777,069 shares⁶$8.4M at $0.10May 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

May 4, 2026Granted 50,000 shares of Inhibitor Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInhibitor Therapeutics, Inc., Chief executive officer
2
SEC EDGARInhibitor Therapeutics, Inc., Board member
3
SEC EDGARBIODELIVERY SCIENCES INTERNATIONAL INC, Board member
4
SEC EDGARInhibitor Therapeutics, Inc., Chair
5
SEC EDGARBIODELIVERY SCIENCES INTERNATIONAL INC, Chair
6
SEC EDGARInhibitor Therapeutics, Inc. shares after the filing of May 4, 2026